179eP NGAL and traditional biomarkers in cervical cancer: A comparative evaluation using random forest

Read full text Summarise with VIRAT
Authors: Behar Raci
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Accurately predicting chemoradiotherapy response is essential to improving patient outcomes, as cervical cancer continues to be a significant worldwide health burden. Finding trustworthy biomarkers could allow for earlier risk assessment and precise treatment.

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Inflammatory Biomarkers in Disease Prognosis Cervical Cancer and HPV Research

Publication details

Journal / source
ESMO Open
Volume
11
Pages
106186–106186
Publication date
1 April 2026
Language
EN